Endoscopic Mucosal Resection Market Size, Share, Growth, and Industry Analysis, By Type (Entry Needle, Mucosectomy Snare, Probe, and Other), By Application (Hospitals, Ambulatory Surgical Centers, Surgical Centers, Others), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

ENDOSCOPIC MUCOSAL RESECTION MARKET OVERVIEW

The global endoscopic mucosal resection market was valued at USD 2.04 billion in 2024 and is projected to reach USD 2.2 billion in 2025, steadily progressing to USD 4.04 billion by 2033, with a CAGR of 7.9% from 2025 to 2033.

Endoscopic mucosal resection (EMR) is a minimally invasive procedure used to remove abnormal or precancerous growths in the gastrointestinal tract. It is commonly performed in the esophagus, stomach, and colon. EMR is an alternative to surgical resection and allows for the removal of abnormal tissues without the need for major surgery. The endoscope is equipped with specialized tools, such as a snare or a suction device, which are used to grasp and remove the abnormal tissue.

The targeted tissue is typically lifted or suctioned into a cap or snare, and then cut or burned away from the underlying layers. Advantages of EMR include its minimally invasive nature, shorter recovery time compared to surgery, and avoidance of more extensive procedures. However, EMR may not be suitable for larger tumor or lesions that have invaded deeper layers of the gastrointestinal wall. In such cases, other treatment options like endoscopic submucosal dissection (ESD) or surgical resection may be recommended.

KEY FINDINGS

COVID-19 IMPACT

Increased Infection Control Measures To Boost Demand Significantly

COVID-19 had a life changing impact globally. The endoscopic mucosal resection market was significantly affected. The virus had various impacts on different markets. Lockdowns were imposed in several nations. This erratic pandemic caused disruptions on all sorts of businesses. Restrictions tightened during the pandemic due to increasing number of cases. Numerous Industries were affected. However, the market for endoscopic mucosal resection experienced an increased demand.

Lockdowns, restrictions, and overwhelmed healthcare systems have limited patient access to healthcare facilities. This has resulted in delayed diagnoses, including the identification of abnormal growths that would require endoscopic mucosal resection. Reduced access to care may have resulted in the progression of certain conditions, potentially requiring more invasive treatment options.

Endoscopic procedures like endoscopic mucosal resection carry a risk of spreading infections, including COVID-19. To minimize this risk, healthcare facilities have implemented enhanced infection control measures, such as pre-procedure screening, personal protective equipment (PPE) requirements, and disinfection protocols. These measures may have impacted the workflow, efficiency, and scheduling of EMR procedures.

LATEST TRENDS

Enhanced Imaging Capabilities to Broaden Market Growth

Several advanced imaging techniques, such as narrow-band imaging (NBI), chromoendoscopy, and confocal laser endomicroscopy (CLE), have been developed to improve the detection and characterization of abnormal lesions. These techniques help endoscopists better visualize the borders and characteristics of the lesions, enabling more precise and targeted endoscopic mucosal resection procedures.

Hybrid endoscopic techniques combine different endoscopic approaches, such as endoscopic mucosal resection and ESD, to optimize lesion removal. For instance, a combination of EMR and ESD may be employed to perform a partial ESD followed by endoscopic mucosal resection for complete resection. These hybrid techniques aim to balance efficacy and safety, especially for larger or challenging lesions. These latest developments are anticipated to boost the endoscopic mucosal resection market share.

• According to the American Cancer Society, approximately 106,590 new cases of colon cancer were diagnosed in the U.S. in 2024, promoting wider adoption of EMR techniques for early-stage tumor removal.

• As per a study published by the National Institutes of Health (NIH), EMR has shown a 91% complete resection rate in early gastrointestinal neoplasia, reinforcing its growing preference over invasive surgeries.

Request a Free sample to learn more about this report

ENDOSCOPIC MUCOSAL RESECTION MARKET SEGMENTATION

By Type

Based on type, the market is divided into entry needle, mucosectomy snare, probe, and other.

Entry needle holds a major share of the global market.

By Application

Based on application, the market is bifurcated into hospitals, ambulatory surgical centers, surgical centers, others.

Hospitals as application holds a major share of the global market.

DRIVING FACTORS

Minimal Invasive Nature to Boost Market Share

EMR is a minimally invasive procedure that can be performed using an endoscope, avoiding the need for open surgery. This approach offers several advantages, including reduced postoperative pain, shorter hospital stays, quicker recovery times, and minimal scarring. EMR can often be an alternative to more invasive surgical procedures, such as partial organ resections. EMR can help avoid the potential complications associated with major surgery, including risks of infection, bleeding, and prolonged recovery.

Early Diagnosis and Therapeutic Capabilities to Boost Market Size

EMR is particularly effective in the early detection and removal of abnormal growths, such as precancerous polyps or early-stage cancers, in the gastrointestinal tract. Early detection allows for a higher chance of successful treatment and improved patient outcomes. EMR serves both diagnostic and therapeutic purposes. It can be used to obtain tissue samples for accurate diagnosis and staging of diseases, while also providing a definitive treatment option for small lesions and early-stage cancers. These factors are anticipated to drive the endoscopic mucosal resection market share.

• According to the World Health Organization (WHO), gastrointestinal cancers account for over 35% of all cancer-related deaths globally, pushing the demand for early detection and removal procedures like EMR.

• The U.S. Preventive Services Task Force recommends colorectal screening from age 45, which adds roughly 21 million more individuals in the U.S. alone to the target demographic for EMR procedures.

RESTRAINING FACTORS

Inadequate Lesion Staging to Hamper Market Share

Accurate staging and characterization of the lesion are crucial for determining the appropriate treatment approach. In some cases, EMR may not be suitable if there is uncertainty about the nature of the lesion or its potential for deeper involvement. Additional diagnostic tests, such as endoscopic ultrasound (EUS) or advanced imaging modalities, may be necessary to improve the assessment and guide treatment decisions. The factors are anticipated to hinder the growth of the endoscopic mucosal resection market share.

• According to the NIH, the recurrence rate after EMR for large polyps can reach up to 20%, raising concerns regarding long-term treatment effectiveness in certain patient groups.

• As per the European Society of Gastrointestinal Endoscopy (ESGE), EMR procedures have a perforation risk of 1.4% and bleeding risk of 6.1%, leading to hesitation among low-volume healthcare centers.

• Request a Free sample to learn more about this report

•  

ENDOSCOPIC MUCOSAL RESECTION MARKET REGIONAL INSIGHTS

Asia-Pacific Dominates the Endoscopic Mucosal Resection Market

APAC is the largest market shareholder for endoscopic mucosal resection market share. The Asia-Pacific region has a relatively high prevalence of gastrointestinal diseases, such as gastric cancer, colorectal cancer, and esophageal cancer. These conditions often require endoscopic interventions, including EMR, for diagnosis, staging, and treatment. The larger patient population with these conditions in the region contributes to a higher demand for EMR procedures. North America is the second major shareholder for the endoscopic mucosal resection share.

KEY INDUSTRY PLAYERS

Market Players Focus on New Product Launches to Strengthen Market Position

Leading players in the market are adopting various strategies to expand their presence in the market. These include R&D investments and launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.   

• CONMED: As per company filings, CONMED’s endoscopic portfolio is used in more than 100 countries, with its EMR devices being applied in over 250,000 procedures annually across global hospitals.

• Boston Scientific Corp.: According to internal data, Boston Scientific has trained over 8,000 gastroenterologists in EMR techniques and offers 30+ specialized tools designed for endoluminal lesion removal.

List of Top Endoscopic Mucosal Resection Companies

• CONMED [U.S.]
• Boston Scientific Corp. [U.S.]
• Cook Medical [U.S.]
• Erbe Elektromedizin GmbH [Germany]
• Interscope Medical [U.S.]
• Olympus [Japan]
• STERIS [U.S.]
• Sumitomo Bakelite Co., Ltd. [Japan]

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.